Advertisement
Loading...

GeneDx Holdings Corp.

WGS•NASDAQ
Healthcare
Medical - Healthcare Information Services
$40.75
$1.90(4.89%)
U.S. Market opens in 61h 34m

GeneDx Holdings Corp. (WGS) Stock Overview

Explore GeneDx Holdings Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.2B
P/E Ratio-15.38
EPS (TTM)$-2.66
ROE-0.28%
Fundamental Analysis

AI Price Forecasts

1 Month$40.58
3 Months$57.29
1 Year Target$152.10

WGS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GeneDx Holdings Corp. (WGS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 33.30, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $152.10.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -15.38 and a market capitalization of 1.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.89%
5-Day Change
0.07%
1-Month Change
-39.59%
3-Month Change
-54.80%
6-Month Change
-68.18%
Year-to-Date (YTD) Change
-68.67%
1-Year Change
-35.94%
3-Year Change
467.55%
5-Year Change
-88.67%
All-Time (Max) Change
-87.40%

Contact Information

http://www.genedx.com
800 298 6470
North Tower, Stamford, CT, 06902

Company Facts

1,000 Employees
IPO DateNov 4, 2020
CountryUS
Actively Trading

Frequently Asked Questions